I reported previously (10th Mar) that Israel’s DreaMed received European approval for its Advisor Pro diabetes monitor. Now the US FDA has given its approval. Advisor Pro provides insulin delivery recommendations by analyzing information from diabetes pumps and glucose monitoring.

https://www.reuters.com/article/us-health-dreamed-fda/israels-dreamed-gets-fda-ok-for-diabetes-management-software-idUSKBN1JE16J